Legal Representation
Attorney
Richard A. Arrett
USPTO Deadlines
Next Deadline
1771 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-28)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 30, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 10, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 10, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Aug 28, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| May 28, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 28, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 21, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| May 1, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| May 1, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 11, 2024 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Feb 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 21, 2024 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Feb 21, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jan 30, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 30, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 30, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 30, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 30, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 29, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 29, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 29, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jan 29, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 29, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 29, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 29, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 21, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 3, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 3, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jun 27, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jun 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 20, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 6, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Dec 2, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 1, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Hydrochlorates; benzene derivatives being industrial chemicals; p-aminophenol; agricultural chemicals, except fungicides, herbicides, insecticides and parasiticides; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; catalysts for oxidation process; biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; catalysts for chemical and biochemical processes
Class 005
Medicines for human purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemico-pharmaceutical preparations for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; drugs for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; biological preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; amino acids for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; active pharmaceutical ingredient, namely amino acids derivatives, chiral or heterocyclic molecular derivatives for medical purposes; chemical reagents for medical or veterinary purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for medical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology; chemical preparations for pharmaceutical purposes for treatment of vascular diseases, diabetes and infectious diseases, and for use in the treatment of diseases and disorders in the fields of oncology, cardiology, immunology, and neurology
Class 040
Recycling of chemicals; water treating; cryopreservation services; medicinal materials processing, namely processing of amino acids derivatives, chiral or heterocyclic molecular derivatives; chemical processing
Additional Information
Design Mark
The mark consists of the capitalized words "CHIRAL QUEST" with a diamond-shaded figured formed by the letters "C" and "Q" at the center. The left part of the figure is a solid black line, and the right part of the figure is a black and white stripe.
Pseudo Mark
CHIRAL CQ QUEST
Pseudo Mark
CHIRAL Q QUEST
Classification
International Classes
001
005
040
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CHIRAL"